IGHE and cancer: Moreover, Josephs et al., by engineering mAbs specific for folate receptors (FRα)—which are widely expressed by human ovarian tumor cells—demonstrated the superior antitumor efficacy of IgE compared to IgG in a syngeneic rat model of cancer [132].